EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 47 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 1,847,500 | $5,709,000 | 0.37% |
Cormorant Asset Management, LP | 896,600 | $2,770,000 | 0.33% |
Broadfin Capital, LLC | 1,375,000 | $4,249,000 | 0.26% |
SOUTHPORT MANAGEMENT, L.L.C. | 25,000 | $77,000 | 0.14% |
TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $6,872,000 | 0.05% |
BAILARD, INC. | 35,000 | $108,000 | 0.05% |
HIGHLAND CAPITAL MANAGEMENT LP | 438,276 | $1,355,000 | 0.04% |
Spark Investment Management LLC | 93,900 | $290,000 | 0.04% |
Abingworth LLP | 7,896 | $24,000 | 0.01% |
SIMPLEX TRADING, LLC | 43,008 | $132,000 | 0.01% |